4.12
+0.105(+2.62%)
Currency In USD
| Previous Close | 4.01 |
| Open | 4.04 |
| Day High | 4.17 |
| Day Low | 3.94 |
| 52-Week High | 7.63 |
| 52-Week Low | 2.37 |
| Volume | 259,131 |
| Average Volume | 1.31M |
| Market Cap | 523.53M |
| PE | -82.3 |
| EPS | -0.05 |
| Moving Average 50 Days | 3.52 |
| Moving Average 200 Days | 4.61 |
| Change | 0.11 |
If you invested $1000 in Cytek Biosciences, Inc. (CTKB) since IPO date, it would be worth $219.35 as of August 18, 2025 at a share price of $4.115. Whereas If you bought $1000 worth of Cytek Biosciences, Inc. (CTKB) shares 3 years ago, it would be worth $292.67 as of August 18, 2025 at a share price of $4.115.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cytek Biosciences to Report Second Quarter 2025 Financial Results on August 6, 2025
GlobeNewswire Inc.
Jul 23, 2025 8:05 PM GMT
FREMONT, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the second quarter 2025 after market close on Wednesday, August 6, 2025
Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
GlobeNewswire Inc.
May 29, 2025 9:00 PM GMT
Improved Sample Throughput, Automation Capabilities and Updated Hardware Design Cytek Aurora™ Evo Cytek today unveiled the Cytek Aurora™ Evo system, a full spectrum flow cytometer that builds on the trusted performance of the Cytek Aurora system. D
Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire Inc.
May 28, 2025 8:05 PM GMT
FREMONT, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming Goldman Sachs 46th Annual Global Healthcare Confe